Key Stats

Expense Ratio Total Assets Under Management Dividend Yield Turnover Ratio
1.92% 257.20M 0.00% 17.00%
1 Year Fund Level Flows 1 Year Total Returns (Daily) Annualized All Time Total Returns (Daily) Max Drawdown (All)
-30.52M -15.54% Upgrade Upgrade

Basic Info

Investment Strategy
The investment seeks long-term growth of capital. The fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets in equity securities (mostly common stocks) of small cap companies located anywhere in the United States. The fund's portfolio managers consider small-capitalization companies to be those companies that, at the time of initial purchase, have a market capitalization equal to or less than the largest company in the Russell 2000® Growth Index during the most recent 12-month period.
General
Security Type Mutual Fund
Oldest Share Symbol UMBHX
Equity Style Small Cap/Growth
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Small Growth
Category Index Russell 2000 Growth TR USD
Global Category Name US Equity Small Cap
YCharts Categorization US Small Cap
YCharts Benchmark Russell 2000 Total Return (^RUTTR)
Prospectus Objective Small Company
Fund Owner Firm Name Carillon Family of Funds
Prospectus Benchmark Index
Russell 2000 Growth TR USD 100.0%
Broad Asset Class Benchmark Index
^SPXTR 100.0%
Manager Tenure
James McBride 12.77 yrs
Timothy Miller 9.34 yrs

Net Fund Flows Versus Category

View Net Fund Flows. Upgrade now.
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
1 Month
% Rank: --
-- Category Low
-- Category High
1 Year
% Rank: 50
-30.52M
-1.393B Category Low
747.16M Category High
3 Months
% Rank: --
-- Category Low
-- Category High
3 Years
% Rank: --
-- Category Low
-- Category High
6 Months
% Rank: --
-- Category Low
-- Category High
5 Years
% Rank: --
-- Category Low
-- Category High
YTD
% Rank: --
-- Category Low
-- Category High
10 Years
% Rank: --
-- Category Low
-- Category High
As of February 28, 2023

Performance Versus Category

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (NAV)
--
--
--
--
--
--
--
--
Category Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Cat (NAV)
--
--
--
--
--
--
--
--
As of March 30, 2023. Returns for periods of 1 year and above are annualized.

Annual Total Returns Versus Peers

Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
11.40%
30.59%
-6.10%
19.72%
34.35%
8.01%
-24.07%
-0.30%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
5.96%
0.12%
35.84%
-9.66%
36.88%
36.78%
-11.73%
-37.55%
5.11%
2.04%
27.10%
8.09%
33.39%
41.62%
3.37%
-25.16%
1.66%
8.58%
16.92%
-10.95%
22.85%
48.05%
6.97%
-32.78%
7.44%
12.59%
17.13%
-8.19%
25.05%
16.93%
10.05%
-28.01%
3.83%
As of March 30, 2023.

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (3-30-23) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 18.15
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of December 31, 2022

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of December 31, 2022

Asset Allocation

As of December 31, 2022.
Type % Net % Long % Short
Cash 0.43% Upgrade Upgrade
Stock 99.57% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other 0.00% Upgrade Upgrade

Top 10 Holdings

Name % Weight Price % Change
Halozyme Therapeutics Inc 2.90% 38.20 2.39%
Medpace Holdings Inc 2.59% 188.02 2.75%
Insperity Inc 2.46% 121.60 2.46%
AMN Healthcare Services Inc 2.29% 82.94 1.44%
Applied Industrial Technologies Inc 2.27% 142.16 2.84%
Performance Food Group Co 2.21% 60.33 1.19%
Box Inc Class A 2.12% 26.78 3.04%
Impinj Inc 2.01% 135.58 1.85%
Fabrinet 1.99% 118.94 3.44%
HealthEquity Inc 1.98% 58.66 1.28%

Fees & Availability

Fees
Actual 12B-1 Fee Upgrade
Actual Management Fee Upgrade
Administration Fee Upgrade
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load Upgrade
Maximum Redemption Fee --
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Purchase Details
Open to New Investors Yes
Open to Existing Investors Yes
Minimum Initial Investment Upgrade
Minimum Subsequent Investment Upgrade

Basic Info

Investment Strategy
The investment seeks long-term growth of capital. The fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets in equity securities (mostly common stocks) of small cap companies located anywhere in the United States. The fund's portfolio managers consider small-capitalization companies to be those companies that, at the time of initial purchase, have a market capitalization equal to or less than the largest company in the Russell 2000® Growth Index during the most recent 12-month period.
General
Security Type Mutual Fund
Oldest Share Symbol UMBHX
Equity Style Small Cap/Growth
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Small Growth
Category Index Russell 2000 Growth TR USD
Global Category Name US Equity Small Cap
YCharts Categorization US Small Cap
YCharts Benchmark Russell 2000 Total Return (^RUTTR)
Prospectus Objective Small Company
Fund Owner Firm Name Carillon Family of Funds
Prospectus Benchmark Index
Russell 2000 Growth TR USD 100.0%
Broad Asset Class Benchmark Index
^SPXTR 100.0%
Manager Tenure
James McBride 12.77 yrs
Timothy Miller 9.34 yrs

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (3-30-23) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 18.15
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of December 31, 2022

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of December 31, 2022

Fund Details

Key Dates
Inception Date 11/20/2017
Last Annual Report Date 10/31/2022
Last Prospectus Date 3/1/2023
Share Classes
CSSAX A
CSSQX Retirement
CSSSX Retirement
CSSVX Retirement
CSSWX Inst
UMBHX Inst
Attributes
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No

Top Portfolio Holders

0 of 0